identifying novel digital measures for fatigue and sleep disturbances that will provide more objective, sensitive and reliable measures of the severity and impact of these symptoms in the person’s normal surrounding.
IDEA-FAST Goals
1
2
Clinical Validation Study
one year longitudinal study with approximately 2000 subjects will be conducted
Data on fatigue, sleep, selected activities of daily living and other relevant contextual information will be collected by smartphone several times a day while using the devices
Data Collection
6
7
Data Analysis
In order to establish which devices are suitable for use, complex data analysis will be performed
The devices that met the criteria will be considered for future use in clinical trials
Validation of devices
8
9
Share & Use
The novel clinically validated digital endpoint will be able to:
offer deeper insight into disease impact
lead to faster clinical development of new therapies
provide a more valid and complete assessment of the impact of diseases and treatments
Latest News
Getting started with the Feasibility Study
After the successful Kick-Off meeting in Newcastle in February, the IDEA-FAST team worked hard to make the vision of the feasibility study come to life. Thanks to the device testing team, we were able [...]
IDEA-FAST Kick-Off Meeting
The project kick-off meeting was organised by Newcastle University and was held at the Newcastle United Football Club. Fai Ng and Fred Baribaud described the concept & approach for the project and strategies for identifying [...]
Press Release
Newcastle upon Tyne, February 05, 2019 – A new European research project to Identify Digital Endpoints to Assess FAtigue, Sleep and acTivities of daily living (acronym: IDEA-FAST) in the following neurodegenerative disorders (NDD): Parkinson’s disease [...]
IDEA-FAST is getting started with the Feasibility Study! More to follow
@IMI_JU @EFPIA @ParkinsonsUK
https://t.co/8eYffd0VyQ
The preparations for our feasibility study to explore #fatigue and #sleep disturbances with the help of #digital technology in different chronic diseases like #PD are in full swing. Now the ethics committee approved the start in Kiel💪 @NeurogeriatricK @IMI_JU @ParkinsonsUK @EFPIA
Day 2 of tackling #fatigue and #sleepdisturbance in #IMID and #ND at the IDEA-FAST kick-off meeting with the help of #wearables and #digitaltechnology. @IMI_JU @EU_H2020 @EFPIA @ParkinsonsUK
